- Patent Title: Determination of the thrombogenic power of human immunoglobulins
-
Application No.: US14343642Application Date: 2011-11-18
-
Publication No.: US09891238B2Publication Date: 2018-02-13
- Inventor: Catherine Michalski
- Applicant: Catherine Michalski
- Applicant Address: FR Les Ulis
- Assignee: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Current Assignee: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Current Assignee Address: FR Les Ulis
- Agency: Young & Thompson
- Priority: FR1059493 20101118
- International Application: PCT/FR2011/052703 WO 20111118
- International Announcement: WO2012/066260 WO 20120524
- Main IPC: C12Q1/56
- IPC: C12Q1/56 ; G01N33/86 ; G01N33/68
Abstract:
A kit for the determination of the thrombogenic power of human immunoglobulins contained in a biologically acceptable product. Also a process making it possible to determine the thrombogenic power linked to the presence of activated Factor XI and/or activated Factor IX and/or activated Factor XII, and/or activated Factor VII and/or activated Factor X in a sample capable of being administered to humans.
Public/Granted literature
- US20140295471A1 DETERMINATION OF THE THROMBOGENIC POWER OF HUMAN IMMUNOGLOBULINS Public/Granted day:2014-10-02
Information query
